During the past decade, Dayton Oncology & Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dayton Oncology & Hematology" #1 sponsor was "Point Therapeutics" with 2 trials, followed by "Abbott" with 1 trials sponsored, "Agennix" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "CytRx" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dayton Oncology & Hematology" #1 collaborator was "US Oncology Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dayton Oncology & Hematology" are "Lung Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Adenocarcinoma" (1 trials), "Carcinoma, Non-Small Cell Lung" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Dayton Oncology & Hematology" in a lesser frequency.

Most popular intervention types in "Dayton Oncology & Hematology" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Prednisone" (2 trials), "ABT-751" (1 trials), "Bortezomib" (1 trials), "Dasatinib" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dayton Oncology & Hematology" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dayton Oncology & Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Dayton Oncology & Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dayton Oncology & Hematology, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".